ArticleInternational journal of molecular sciences2023

Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent.

Harold A Chinyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.